Regulation of androgen receptor expression by Z‐isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer
Authors:
- 4 October 2012
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 73 (5) , 531-541
Abstract
BACKGROUND: The androgen receptor (AR) is a main therapeutic target for treatment of prostate cancer (PCa). The natural compound isochaihulactone (K8), which has a chiral center ring and two racemic forms (E‐K8 and Z‐K8), has anti‐tumor effects on multiple cancer types both in vitro and in vivo. Here, we determined which form of K8 contains significant tumor cytotoxicity and examined how this form regulates AR expression in PCa cells and xenografts.METHODS: We chose the androgen‐dependent human PCa cell line LNCaP and the androgen‐independent cell lines DU145 and PC‐3 to study the anti‐tumor potency and AR regulation mediated by Z‐K8. We measured cell viability and used flow cytometry, RT‐PCR, and Western blotting. Growth inhibition in vivo was evaluated with an LNCaP xenograft animal model.RESULTS: In LNCaP cells, Z‐K8 significantly repressed cell proliferation, induced apoptosis, repressed AR mRNA and protein expression in a time‐dependent manner, and induced JNK phosphorylation. Furthermore, treatment with a JNK inhibitor significantly abolished Z‐K8‐induced AR downregulation. Z‐K8 did not significantly inhibit reporter gene expression of constructs containing the AR promoter when it contained a mutated Sp1 binding site. Z‐K8 also showed anti‐tumor effects in the xenograft animal model.CONCLUSION: Z‐K8 not only induced LNCaP apoptosis but also reduced AR expression. These results indicate that Z‐K8 may be a potential anti‐tumor drug for PCa therapy. Prostate 73: 531–541, 2013.Keywords
This publication has 21 references indexed in Scilit:
- Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cellsBMC Cancer, 2011
- Lignans Isolated from Campylotropis hirtella (Franch.) Schindl. Decreased Prostate Specific Antigen and Androgen Receptor Expression in LNCaP CellsJournal of Agricultural and Food Chemistry, 2008
- Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenograftsThe Prostate, 2007
- PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptorThe Prostate, 2006
- Small-interfering RNA–induced androgen receptor silencing leads to apoptotic cell death in prostate cancerMolecular Cancer Therapeutics, 2005
- Requirement for ERK activation in acetone extract identified from Bupleurrum scorzonerifolium induced A549 tumor cell apoptosis and keratin 8 phosphorylationLife Sciences, 2005
- Real‐time whole‐body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent proteinThe Prostate, 2004
- ANDROGEN RECEPTOR DOWN-REGULATION IN PROSTATE CANCER WITH PHOSPHORODIAMIDATE MORPHOLINO ANTISENSE OLIGOMERSJournal of Urology, 2004
- Induction of orphan nuclear receptor Nur77 gene expression and its role in cadmium-induced apoptosis in lungCarcinogenesis, 2004
- Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesCancer Gene Therapy, 2000